Education
About Us
Working with TipRanks
Follow Us
Mark Casey Insider Profile
4 Followers
Mark Casey, SVP, CAO, GC & Secretary at Hologic, holds 31.97K shares in Novavax (Ticker: NVAX), holds 0.00 shares in Mallinckrodt (Ticker: MNKKQ), holds 0.00 shares in Aceragen (Ticker: ACGN).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-0.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Casey holds in companies
Most Profitable Insider Trade
Stock:
Mallinckrodt
(MNKKQ)
(MNKKQ)
Rating:Informative Sell
Date:Dec 18, 2020 - Dec 18, 2021
Return:+58.70%
The most profitable trade made by Mark Casey
Mark Casey's Trading History
Hologic
Nov 19, 2014
SVP, CAO, GC & Secretary
Uninformative Sell
29.06K
$950.35K
Mallinckrodt
Jun 21, 2022
―
Uninformative Sell
―
$0.00
Novavax
Mar 04, 2025
EVP, CLO
Uninformative Buy
23.21K
$266.65K
Aceragen
May 13, 2016
―
Informative Buy
49.61K
$0.00
List of latest transactions for each holding click on a transaction to see Mark Casey's performance on stock
You May Also Like
Mark Casey insider profile FAQ
What is the percentage of profitable transactions made by Mark Casey?
The percentage of profitable transactions made by Mark Casey is 50%.
What is the average return per transaction made by Mark Casey?
The average return per transaction made by Mark Casey is -0.40%.
What stocks does Mark Casey hold?
Mark Casey holds: HOLX, MNKKQ, NVAX, ACGN stocks.
What was Mark Casey’s latest transaction?
Mark Casey latest transaction was an Uninformative Buy of $23.21K.
What was Mark Casey's most profitable transaction?
Mark Casey’s most profitable transaction was an Informative Sell of MNKKQ stock on December 18, 2020. The return on the trade was 58.70%.
What is Mark Casey's role in Hologic?
Mark Casey's role in Hologic is SVP, CAO, GC & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.